At a glance
ClinicalIndex Comparison RecordN/ACompleted· 175 enrolled
Drug / intervention
EVIA Pacemakerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Master Study of the EVIA DR-T/DR/SR-T/SR Pacemaker
In Brief
A clinical study evaluating EVIA Pacemaker for Pacemaker Indication. Completed, enrolled 175 participants across 1 site.
Detailed Summary
The objective of this study is to prove the safety and efficacy of the EVIA pacemaker. Primarily, the newly implemented Atrial Capture Control algorithm is evaluated, which automatically measures the right atrial threshold and subsequently adjusts the pacing output.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPacemaker Indication
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
First PostedJun 2009
Primary CompletionFeb 2010
Study CompletionMar 2010
TodayJul 2026
First PostedJun 9, 2009
Enrollment StartJun 1, 2009
Primary CompletionFeb 1, 2010
Study CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 17.1 years ago
Interventions
EVIA Pacemakerdevice
patient has standard indication for pacemaker therapy